Food and Drug Law Institute
FDA’s 2016 New Dietary Ingredient Draft Guidance: Promise and Challenge for Dietary Supplement Innovation
January/February 2017
On August 12, 2016, FDA issued a new Draft Guidance (Draft Guidance) on its interpretation of the New Dietary Ingredient (NDI) notification requirement in Section 413 of the Federal Food, Drug, and Cosmetic Act (FDCA). The Draft Guidance contains provisions that have the potential both to facilitate and to impede innovation in the dietary supplement and functional food industries.
Contacts
Capabilities
Suggested News & Insights
Sidley Represents Changchun GeneScience (GenSci) Pharmaceuticals in Its Strategic Licensing Agreement With Yarrow Bioscience for First-in-Class Autoimmune Thyroid Disease TherapyDecember 18, 2025Sidley Represents Immunovant in US$550 Million OfferingDecember 12, 2025BIOSECURE Act Included in the FY2026 National Defense Authorization ActDecember 12, 2025What the U.S.–UK Drug Pricing Agreement Reveals About How MFN Drug Policy Could Impact the UK and EUDecember 10, 2025U.S. FDA's Adoption of ICH E6(R3) Good Clinical Practice: Key Takeaways for Sponsors and InvestigatorsDecember 4, 2025Sidley Represents PayRange in Its Acquisition of KioSoftDecember 1, 2025
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory